Prof. Michel Farnier discusses "Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING)".
Welcome to the third newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Welcome to the second newsletter summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
Welcome to a series of newsletters summarizing the latest clinical and real-world evidence in dyslipidemia and reflecting on the clinical impact of these data on dyslipidemia management.
